Human Health and Heredity in Africa: Research Grants Program
Page 2

The Human Health and Heredity in Africa: Research Grants Program was initially created to address the concerns of low and middle-income nations who are having the difficulty to safeguard and sustain the health and well-being of its people.

The target counties often face the burden of having to deal with various health conditions such as infectious diseases, malnutrition, and a growing number of chronic diseases.

The project aims to address this concerns by focusing the scope of the research studies in the following areas:

1) Genetic/environmental contributors to non-communicable disease in Africa

2) Genetic/environmental contributors to communicable disease in Africa

3) Contribution of the human microbiome to health and disease in Africa

4) The occurence of Mendelian diseases in Africa

5) The field of Pharmacogenics

The National Institutes of Health is set to administer a total funding amount of $1.25 million per year, which can last up to four years.

The institutions and organizations that are eligible to submit an application under Human Health and Heredity in Africa: Research Grants Program are the following:

a) Non-domestic (non-U.S.) Entities (African Institutions) such as African institutions, Public/State Controlled Institutions of Higher Education, and Private Institutions of Higher Education

b) Non domestic foreign institutions.

Human Health and Heredity in Africa: Research Grants Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

National Heart, Lung, and Blood Institute Career Transition Award
In keeping with this mission, the National Institutes of Health has collaborated with the National Heart, Lung, and Blood Institute to establish the National Heart, Lung, and Blood Institute (NHLBI) Career Transition Award Program.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Physical and Engineering Sciences in Oncology
The National Science Foundation, in close cooperation the National Cancer Institute, has recently developed the Physical and Engineering Sciences in Oncology Program wherein they intend to obtain a more thorough understanding of cancer disorders with the application of physical and engineering sciences.

---